Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 29,741Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 42NOVARTIS

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

RIBOCICLIB SUCCINATE

US Patent Number : 8962630

Drug Substance Claim :

Drug Product Claim :

Application Number : 209092

Patent Use Code : U-1981

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-12-09

blank

02

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

RIBOCICLIB SUCCINATE

US Patent Number : 8962630

Drug Substance Claim :

Drug Product Claim :

Application Number : 209092

Patent Use Code : U-2356

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-12-09

blank

03

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

RIBOCICLIB SUCCINATE

US Patent Number : 8962630

Drug Substance Claim :

Drug Product Claim :

Application Number : 209092

Patent Use Code : U-2355

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-12-09

blank

04

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

RIBOCICLIB SUCCINATE

US Patent Number : 9868739

Drug Substance Claim :

Drug Product Claim :

Application Number : 209092

Patent Use Code : U-2355

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-11-09

blank

05

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

RIBOCICLIB SUCCINATE

US Patent Number : 9868739

Drug Substance Claim :

Drug Product Claim :

Application Number : 209092

Patent Use Code : U-2356

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-11-09

blank

06

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

RIBOCICLIB SUCCINATE

US Patent Number : 9416136

Drug Substance Claim :

Drug Product Claim :

Application Number : 209092

Patent Use Code : U-2355

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-08-20

blank

07

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

RIBOCICLIB SUCCINATE

US Patent Number : 9416136

Drug Substance Claim :

Drug Product Claim :

Application Number : 209092

Patent Use Code : U-2356

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-08-20

blank

08

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

LETROZOLE; RIBOCICLIB SUCCINATE

US Patent Number : 8962630

Drug Substance Claim :

Drug Product Claim :

Application Number : 209935

Patent Use Code : U-2505

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-12-09

blank

09

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

LETROZOLE; RIBOCICLIB SUCCINATE

US Patent Number : 9416136

Drug Substance Claim :

Drug Product Claim :

Application Number : 209935

Patent Use Code : U-2505

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-08-20

blank

10

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

RIBOCICLIB SUCCINATE

US Patent Number : 9416136

Drug Substance Claim :

Drug Product Claim :

Application Number : 209092

Patent Use Code : U-1981

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-08-20

blank